Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201308053 Principal Investigator: Vij, Ravi
Title: Phase 1/2 Clinical Trial of NPI-0052 in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma
Phase: I/II Disease Site: Multiple Myeloma
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find out if an investigational drug known as marizomib (NPI-0052) has an effect on multiple myeloma.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)